4934.T) released its earnings presentation for Q2 FY2026. Revenue was ¥8.53 billion.">
PULSE NEWS WIRE
Clear, Actionable Intelligence
<2 min
Avg Latency
24/5
Coverage

Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.

This corporate disclosure from Premier Anti-Aging Co.,Ltd. was processed by Pulse News Wire on March 12, 2026. It represents a primary source document for Japanese Earnings sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.

Premier Anti-Aging Co.,Ltd. Reports Q2 FY2026 Earnings Presentation: Revenue of 8.53 billion

TOKYO, Mar 12 (Pulse News Wire) – Premier Anti-Aging Co.,Ltd. (4934.T) released its earnings presentation for Q2 FY2026. Revenue was ¥8.53 billion. Operating profit was ¥977 million. Ordinary profit

View all 4934.T disclosures →

Share this disclosure: Share on X Share on LinkedIn